Sakatani T - Search Results

1

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).

Uematsu S, Kitazono S, Tanaka H, Saito R, Kawashima Y, Ohyanagi F, Tozuka T, Ryosuke T, Sakatani T, Horiike A, Yoshizawa T, Saiki M, Tambo Y, Koyama J, Kanazu M, Kudo K, Tsuchiya-Kawano Y, Yanagitani N, Nishio M. Uematsu S, et al. Among authors: sakatani t. Thorac Cancer. 2023 Jan;14(2):168-176. doi: 10.1111/1759-7714.14729. Epub 2022 Nov 21. Thorac Cancer. 2023. PMID: 36408699 Free PMC article.

2

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor.

Sakai K, Horiike A, Irwin DL, Kudo K, Fujita Y, Tanimoto A, Sakatani T, Saito R, Kaburaki K, Yanagitani N, Ohyanagi F, Nishio M, Nishio K. Sakai K, et al. Among authors: sakatani t. Cancer Sci. 2013 Sep;104(9):1198-204. doi: 10.1111/cas.12211. Epub 2013 Jul 1. Cancer Sci. 2013. PMID: 23721103 Free PMC article.

3

Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients: phase II study.

Kawano Y, Ohyanagi F, Yanagitani N, Kudo K, Horiike A, Tanimoto A, Nishizawa H, Ichikawa A, Sakatani T, Nakatomi K, Hagiwara S, Ninomiya H, Motoi N, Ishikawa Y, Horai T, Nishio M. Kawano Y, et al. Among authors: sakatani t. Anticancer Res. 2013 Aug;33(8):3327-33. Anticancer Res. 2013. PMID: 23898099 Clinical Trial.

4

A phase II study of S-1 in relapsed small cell lung cancer.

Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Tahanaka H, Yanagitani N, Saito R, Kaburaki K, Sakatani T, Horai T, Nishio M. Kudo K, et al. Among authors: sakatani t. Mol Clin Oncol. 2013 Mar;1(2):263-266. doi: 10.3892/mco.2013.67. Epub 2013 Jan 14. Mol Clin Oncol. 2013. PMID: 24649158 Free PMC article.

5

Phase II study of docetaxel-plus-bevacizumab combination therapy in patients previously treated for advanced non-squamous non-small cell lung cancer.

Ohyanagi F, Yanagitani N, Kudo K, Kawano Y, Sakatani T, Tanimoto A, Nishizawa H, Horiike A, Hagiwara S, Horai T, Nishio M. Ohyanagi F, et al. Among authors: sakatani t. Anticancer Res. 2014 Sep;34(9):5153-8. Anticancer Res. 2014. PMID: 25202107 Clinical Trial.

6

Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation.

Tanaka H, Horiike A, Sakatani T, Saito R, Yanagitani N, Kudo K, Ohyanagi F, Horai T, Nishio M. Tanaka H, et al. Among authors: sakatani t. Anticancer Drugs. 2015 Jun;26(5):573-8. doi: 10.1097/CAD.0000000000000220. Anticancer Drugs. 2015. PMID: 25714250

7

Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).

Hasegawa T, Ariyasu R, Tanaka H, Saito R, Kawashima Y, Horiike A, Sakatani T, Tozuka T, Shiihara J, Saiki M, Tambo Y, Sonoda T, Miyazaki A, Uematsu S, Tsuchiya-Kawano Y, Yanagitani N, Nishino M. Hasegawa T, et al. Among authors: sakatani t. Cancer Chemother Pharmacol. 2023 Jul;92(1):29-37. doi: 10.1007/s00280-023-04547-2. Epub 2023 May 27. Cancer Chemother Pharmacol. 2023. PMID: 37243795

8

Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma.

Maemura K, Watanabe K, Ando T, Hiyama N, Sakatani T, Amano Y, Kage H, Nakajima J, Yatomi Y, Nagase T, Takai D. Maemura K, et al. Among authors: sakatani t. Cancer Sci. 2018 Oct;109(10):3326-3335. doi: 10.1111/cas.13742. Epub 2018 Sep 6. Cancer Sci. 2018. PMID: 30022565 Free PMC article.

9

Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report.

Taniguchi Y, Yamamoto M, Ikushima H, Ohara S, Takeshima H, Sakatani T, Usui K. Taniguchi Y, et al. Among authors: sakatani t. Case Rep Oncol. 2019 Jul 16;12(2):564-567. doi: 10.1159/000501848. eCollection 2019 May-Aug. Case Rep Oncol. 2019. PMID: 31427953 Free PMC article.

10

Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer.

Sakatani T, Kage H, Takayanagi S, Watanabe K, Hiraishi Y, Shinozaki-Ushiku A, Tanaka S, Ushiku T, Saito N, Nagase T. Sakatani T, et al. Case Rep Oncol Med. 2019 Jun 17;2019:9141870. doi: 10.1155/2019/9141870. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31316849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page